Article info
PDFClinical trials and drug discovery
Risk of adverse events from different drugs for SLE: a systematic review and network meta-analysis
- Correspondence to Dr Qianjin Lu, Department of Dermatology, Hunan Key Laboratory ofMedical Epigenomics, The Second Xiangya Hospital, Central South University,Changsha, Hunan 410011, China. ; qianlu5860{at}gmail.com
Citation
Risk of adverse events from different drugs for SLE: a systematic review and network meta-analysis
Publication history
- Received December 2, 2017
- Revision received February 1, 2018
- Accepted February 16, 2018
- First published March 9, 2018.
Online issue publication
March 09, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/